Stock Scorer

YD Bio Ltd (YDES) · Insider trading

What YD Bio's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$128,525
1 insider, 3 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
+$128,525
bought less sold
Latest filing
2026-10-06
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2026-01 2026-07 2026-09: $128,525 bought
Bought Sold Largest month: $128,525

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Shen Ethan PhDDirector, CEO $128,525 – 3 2026-09-14 11,258,331

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-09-14 Shen Ethan PhDDirector, CEO Buy 12,700 3.85 $48,895 11,258,331 Form 4
2026-09-09 Shen Ethan PhDDirector, CEO Buy 3,100 3.93 $12,183 11,245,631 Form 4
2026-09-04 Shen Ethan PhDDirector, CEO Buy 18,378 3.67 $67,447 11,242,531 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

6 × option exercise
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-30 Chang KochiDirector Option exercise M +3,135 – 10,965 Form 4
2026-09-30 Lu Shao-TaDirector Option exercise M +3,135 – 10,965 Form 4
2026-06-30 Chang KochiDirector Option exercise M +5,749 – 7,830 Form 4
2026-06-30 Lu Shao-TaDirector Option exercise M +5,749 – 7,830 Form 4
2026-03-31 Chang KochiDirector Option exercise M +2,081 – 2,081 Form 4
2026-03-31 Lu Shao-TaDirector Option exercise M +2,081 – 2,081 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

YD Bio's scores and multiples ›